Prelude Therapeutics Ends 2023 on a Strong Note, Targets New Milestones in 2024
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has reported its fiscal results for the year end of December 31, 2023. It also set forth its objectives for the coming …
Prelude Therapeutics Ends 2023 on a Strong Note, Targets New Milestones in 2024 Read More